Basic Information
| RNALocate ID: | RLID:11003863 |
| RNA Symbol: | hsa-miR-34b-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-34b |
| RNA ID: | miRBase:MIMAT0004676 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23771658 |
| Tissue/Cell Line: | Hepatoma cells |
| Method: | Microarray|qRT-PCR |
| Description: | In line with the difference in number of detectable miRNAs, the expression levels of these miRNAs also varied between MVs and cells. Statistical analysis of the 148 co-expressing miRNAs showed that 25 miRNAs were aberrantly elevated inMVs and 75 miRNAs were significantly elevated in cells with more than two folds change. Forty-eight miRNAs had the similar signal intensity in both groups (table 1). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003860 | Exosome | Serum | 18589210 |
| RLID:11003861 | Exosome | Plasma | 23663360 |
| RLID:11003862 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11003864 | Microvesicle | Serum | 24797360 |
| RLID-D:11000652 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001525 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-34b-3p | Oral squamous cell carcinoma | MNDR-E-MI-42814 |
| MNDR | hsa-miR-34b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42815 |
| MNDR | hsa-miR-34b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-42816 |
| MNDR | hsa-miR-34b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42817 |
| MNDR | hsa-miR-34b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42818 |
| MNDR | hsa-miR-34b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-42819 |
| MNDR | hsa-miR-34b-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-42820 |
| MNDR | hsa-miR-34b-3p | Prostate cancer | MNDR-E-MI-42821 |
| MNDR | hsa-miR-34b-3p | Alzheimer disease | MNDR-E-MI-42822 |
| MNDR | hsa-miR-34b-3p | Intracranial aneurysm | MNDR-E-MI-42823 |
| MNDR | hsa-miR-34b-3p | Myotonic dystrophy | MNDR-E-MI-42824 |
| MNDR | hsa-miR-34b-3p | Head and neck cancer | MNDR-E-MI-42825 |
| MNDR | hsa-miR-34b-3p | Huntington disease | MNDR-E-MI-42826 |
| MNDR | hsa-miR-34b-3p | Chorea | MNDR-E-MI-42827 |
| MNDR | hsa-miR-34b-3p | Lung cancer | MNDR-E-MI-42828 |
| MNDR | hsa-miR-34b-3p | Parkinson disease | MNDR-E-MI-42829 |
| MNDR | hsa-miR-34b-3p | Machado-joseph disease | MNDR-E-MI-42830 |
| MNDR | hsa-miR-34b-3p | Breast cancer | MNDR-E-MI-42831 |
| MNDR | hsa-miR-34b-3p | Pituitary neoplasms | MNDR-E-MI-42832 |
| MNDR | hsa-miR-34b-3p | Pancreatic cancer | MNDR-E-MI-42833 |
| MNDR | hsa-miR-34b-3p | Colon cancer | MNDR-E-MI-42834 |
| MNDR | hsa-miR-34b-3p | Familial ovarian cancer | MNDR-E-MI-42835 |
| MNDR | hsa-miR-34b-3p | Carcinoma ductal breast | MNDR-E-MI-42836 |
| MNDR | hsa-miR-34b-3p | Glioblastoma | MNDR-E-MI-42837 |
| MNDR | hsa-miR-34b-3p | Glioma | MNDR-E-MI-42838 |
| MNDR | hsa-miR-34b-3p | Epilepsy temporal lobe | MNDR-E-MI-42839 |
| MNDR | hsa-miR-34b-3p | Liposarcoma | MNDR-E-MI-42840 |
| MNDR | hsa-miR-34b-3p | Uterine cancer | MNDR-E-MI-42841 |
| MNDR | hsa-miR-34b-3p | Lung squamous cell carcinoma | MNDR-E-MI-42842 |
| MNDR | hsa-miR-34b-3p | Lung adenocarcinoma | MNDR-E-MI-42843 |
| MNDR | hsa-miR-34b-3p | Thyroid carcinoma | MNDR-E-MI-42844 |
| MNDR | hsa-miR-34b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-42845 |
| MNDR | hsa-miR-34b-3p | Clear cell renal cell carcinoma | MNDR-E-MI-42846 |
| MNDR | hsa-miR-34b-3p | Cholangiocarcinoma | MNDR-E-MI-42847 |
| MNDR | hsa-miR-34b-3p | Esophageal cancer | MNDR-E-MI-42848 |
| MNDR | hsa-miR-34b-3p | Lung small cell carcinoma | MNDR-E-MI-42849 |
| MNDR | hsa-miR-34b-3p | Synovial sarcoma | MNDR-E-MI-42850 |
| MNDR | hsa-miR-34b-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-42851 |
| MNDR | hsa-miR-34b-3p | Breast invasive carcinoma | MNDR-E-MI-42852 |
| MNDR | hsa-miR-34b-3p | Hepatocellular carcinoma | MNDR-E-MI-42853 |
| MNDR | hsa-miR-34b-3p | Familiar ovarian carcinoma | MNDR-E-MI-42854 |
| MNDR | hsa-miR-34b-3p | Malignant pleural mesothelioma | MNDR-E-MI-42855 |
| MNDR | hsa-miR-34b-3p | Barrett's adenocarcinoma | MNDR-E-MI-42856 |
| MNDR | hsa-miR-34b-3p | Burkitt lymphoma | MNDR-E-MI-42857 |
| MNDR | hsa-miR-34b-3p | Colorectal cancer | MNDR-E-MI-42858 |
| MNDR | hsa-miR-34b-3p | Nasopharynx carcinoma | MNDR-E-MI-42859 |
| MNDR | hsa-miR-34b-3p | Acute lymphocytic leukemia | MNDR-E-MI-42860 |
| MNDR | hsa-miR-34b-3p | Nasopharyngeal cancer | MNDR-E-MI-42861 |
| MNDR | hsa-miR-34b-3p | Barrett's carcinogenesis | MNDR-E-MI-42862 |
| MNDR | hsa-miR-34b-3p | Breast cancer her3+ negative | MNDR-E-MI-42863 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AXL | Homo sapiens | RR00168797 |
TOP